Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75.9M
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
4.86M
-
Shares change
-
+168K
-
Total reported value, excl. options
-
$103M
-
Value change
-
+$3.57M
-
Number of buys
-
3
-
Number of sells
-
-6
-
Price
-
$21.11
Significant Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q4 2016
13 filings reported holding MRUS - Merus N.V. - Common Shares, Euro 0.09 nominal value per share as of Q4 2016.
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.86M shares
of 75.9M outstanding shares and own 6.41% of the company stock.
Largest 10 shareholders include Novo A/S (1.41M shares), BAKER BROS. ADVISORS LP (1.16M shares), FRANKLIN RESOURCES INC (636K shares), Tekla Capital Management LLC (479K shares), Rock Springs Capital Management LP (400K shares), PRICE T ROWE ASSOCIATES INC /MD/ (398K shares), Iguana Healthcare Management, LLC (150K shares), PLATINUM INVESTMENT MANAGEMENT LTD (112K shares), MILLENNIUM MANAGEMENT LLC (78.8K shares), and NORGES BANK (37.4K shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.